The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1610
ISSUE 1610
November 2, 2020
Issue 1610
- Antiviral Drugs for Influenza for 2020-2021
- Large-Volume, Preservative-Free Albuterol Concentrate
- In Brief: New Benzodiazepine Warnings
- In Brief: New Warnings on NSAID Use in Pregnancy
- In Brief: Extended-Release Budesonide (Ortikos) for Crohn's Disease
- Comparison Chart: Antiviral Drugs for Influenza (online only)
| Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue. |
Antiviral Drugs for Influenza for 2020-2021
November 2, 2020 (Issue: 1610)
Influenza is generally a self-limited illness, but
complications such as pneumonia, respiratory failure,
and death can occur, especially in patients at increased
risk for influenza complications (see Table 1).
Antiviral drugs recommended for treatment and
chemoprophylaxis of influenza this season are listed
in Table 2. Updated information on influenza activity
and antiviral resistance is available from the CDC at
www.cdc.gov/flu.
... more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this issue? Gain access below.
Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App for iOS, Android, and Kindle Fire
- FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1610
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian
